BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 28157718)

  • 1. In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves.
    Aguiari P; Iop L; Favaretto F; Fidalgo CM; Naso F; Milan G; Vindigni V; Spina M; Bassetto F; Bagno A; Vettor R; Gerosa G
    Biomed Mater; 2017 Feb; 12(1):015021. PubMed ID: 28157718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation material bovine pericardium: biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing.
    Hülsmann J; Grün K; El Amouri S; Barth M; Hornung K; Holzfuß C; Lichtenberg A; Akhyari P
    Xenotransplantation; 2012; 19(5):286-97. PubMed ID: 22978462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomechanical characterization of decellularized and cross-linked bovine pericardium.
    Oswal D; Korossis S; Mirsadraee S; Wilcox H; Watterson K; Fisher J; Ingham E
    J Heart Valve Dis; 2007 Mar; 16(2):165-74. PubMed ID: 17484467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes.
    Grefen L; König F; Grab M; Hagl C; Thierfelder N
    J Mater Sci Mater Med; 2018 Nov; 29(11):172. PubMed ID: 30392024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic acellular detoxified glutaraldehyde cross-linked bovine pericardium for tissue engineering.
    Mathapati S; Bishi DK; Guhathakurta S; Cherian KM; Venugopal JR; Ramakrishna S; Verma RS
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1561-72. PubMed ID: 23827609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of pig and human-derived aortic valve interstitial cells seeding on fixative-free decellularized animal pericardium.
    Santoro R; Consolo F; Spiccia M; Piola M; Kassem S; Prandi F; Vinci MC; Forti E; Polvani G; Fiore GB; Soncini M; Pesce M
    J Biomed Mater Res B Appl Biomater; 2016 Feb; 104(2):345-56. PubMed ID: 25809726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tissue treatment to reduce mineralization of bovine pericardial heart valves.
    Meuris B; De Praetere H; Strasly M; Trabucco P; Lai JC; Verbrugghe P; Herijgers P
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):197-206. PubMed ID: 29572021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of a polymer layered bio-hybrid heart valve scaffold.
    Jahnavi S; Kumary TV; Bhuvaneshwar GS; Natarajan TS; Verma RS
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():263-73. PubMed ID: 25842134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the suitability of decellularized porcine pericardium in mitral valve reconstruction.
    Morticelli L; Thomas D; Roberts N; Ingham E; Korossis S
    J Heart Valve Dis; 2013 May; 22(3):340-53. PubMed ID: 24151760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of PVPAC-treated bovine pericardium: a potential replacement for glutaraldehyde in biological heart valves.
    Barros JA; Filippin-Monteiro FB; de Oliveira EM; Campa A; Catalani LH; Pitombo Rde N; Polakiewicz B
    J Biomed Mater Res B Appl Biomater; 2014 Apr; 102(3):574-82. PubMed ID: 24123957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo biomechanical assessment of triglycidylamine crosslinked pericardium.
    Sacks MS; Hamamoto H; Connolly JM; Gorman RC; Gorman JH; Levy RJ
    Biomaterials; 2007 Dec; 28(35):5390-8. PubMed ID: 17822757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves.
    Yang M; Chen CZ; Wang XN; Zhu YB; Gu YJ
    J Biomed Mater Res B Appl Biomater; 2009 Oct; 91(1):354-61. PubMed ID: 19507136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological effects of processed bovine pericardial scaffolds--a comparative in vivo evaluation.
    Thampi P; Nair D; R L; N V; Venugopal S; Ramachandra U
    Artif Organs; 2013 Jul; 37(7):600-5. PubMed ID: 23452255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue.
    Bianco RW; Phillips R; Mrachek J; Witson J
    J Heart Valve Dis; 1996 May; 5(3):317-22. PubMed ID: 8793684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material.
    Grabenwöger M; Sider J; Fitzal F; Zelenka C; Windberger U; Grimm M; Moritz A; Böck P; Wolner E
    Ann Thorac Surg; 1996 Sep; 62(3):772-7. PubMed ID: 8784007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-crosslinked acellular bovine pericardium for the application of calcification inhibition heart valves.
    Liu J; Li B; Jing H; Qin Y; Wu Y; Kong D; Leng X; Wang Z
    Biomed Mater; 2020 May; 15(4):045002. PubMed ID: 31972553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties.
    Tam H; Zhang W; Infante D; Parchment N; Sacks M; Vyavahare N
    J Cardiovasc Transl Res; 2017 Apr; 10(2):194-205. PubMed ID: 28213846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tensile properties of xenopericardium from three animal species and finite element analysis for bioprosthetic heart valve tissue.
    Rassoli A; Fatouraee N; Guidoin R; Zhang Z
    Artif Organs; 2020 Mar; 44(3):278-287. PubMed ID: 31386771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of an acellular bovine pericardium intended for manufacture of valve bioprostheses.
    Goissis G; Giglioti Ade F; Braile DM
    Artif Organs; 2011 May; 35(5):484-9. PubMed ID: 21595716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detoxification and endothelialization of glutaraldehyde-fixed bovine pericardium with titanium coating: a new technology for cardiovascular tissue engineering.
    Guldner NW; Jasmund I; Zimmermann H; Heinlein M; Girndt B; Meier V; Flüss F; Rohde D; Gebert A; Sievers HH
    Circulation; 2009 Mar; 119(12):1653-60. PubMed ID: 19289635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.